Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)UnknownNCT03452657
What this trial is testing

Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

Who this might be right for
Diabetic RetinopathyRanibizumab
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 118
Not applicableStudy completedNCT03345667
What this trial is testing

Assessment of Color Vision in Diabetic Patients

Who this might be right for
Retinopathy, Diabetic
Instituto de Olhos de Goiania 30
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244978
What this trial is testing

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 49
Not applicableStudy completedNCT00978926
What this trial is testing

The Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancy
National University Hospital, Singapore
Large-scale testing (Phase 3)Study completedNCT00028990
What this trial is testing

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 722
Large-scale testing (Phase 3)Not Yet RecruitingNCT07520318
What this trial is testing

This is a 96-week, Multicenter Study in Patients With Neovascular AMD That Evaluates OCUL101 for Efficacy, Safety, Durability, and Pharmacokinetics, Comparing it With Another Treatment. The Study Will be Conducted in Two Parts, Part A and Part B.

Who this might be right for
Adults With Neovascular Age-related Macular Degeneration
Shenzhen Oculgen Biomedical Technology Co., Ltd. 255
Not applicableStudy completedNCT01644513
What this trial is testing

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Who this might be right for
Age Related Macular Degeneration
Sequenom, Inc. 196
Large-scale testing (Phase 3)Looking for participantsNCT06888817
What this trial is testing

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Who this might be right for
Radiation NecrosisHigh Grade Glioma (III or IV)Brain Metastasases+4 more
The Netherlands Cancer Institute 408
Large-scale testing (Phase 3)UnknownNCT05539235
What this trial is testing

Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD

Who this might be right for
Exudative Age-Related Macular Degeneration
First Affiliated Hospital of Chongqing Medical University 60
Not applicableUnknownNCT03128463
What this trial is testing

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

Who this might be right for
Age-Related Macular DegenerationPolypoidal Choroidal VasculopathyPathological Myopia+2 more
Xun Xu 5,000
Early research (Phase 1)Ended earlyNCT03396861
What this trial is testing

Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept

Who this might be right for
Irvine-Gass Syndrome
Tufts Medical Center 1
Post-approval studies (Phase 4)Looking for participantsNCT07133438
What this trial is testing

Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment

Who this might be right for
Retinal Vein Occlusion (RVO)
First Affiliated Hospital of Chongqing Medical University 120
Not applicableStudy completedNCT05146687
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 369,600
Testing effectiveness (Phase 2)Study completedNCT00025389
What this trial is testing

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Chicago 8
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Not applicableEnded earlyNCT03699618
What this trial is testing

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Submacular HemorrhageWet Macular DegenerationNeovascular Age-related Macular Degeneration
Johns Hopkins University 1
Testing effectiveness (Phase 2)Study completedNCT00066846
What this trial is testing

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Next Page